Citations

Clear

16280 citation(s) found for "Yu, David".

Impact of Prehospital Electrocardiogram Protocol and Immediate Catheterization Team Activation for Patients With ST-Elevation–Myocardial Infarction
Nestler, David M. , White, Roger D., Rihal, Charanjit S. , Myers, Lucas A. , Bjerke, Christine M., Lennon, Ryan J. , Schultz, Jeffery L., Bell, Malcolm R. , Holmes, David R. , Ting, Henry H. , Rihal, Charanjit S. , Gersh, Bernard J.

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | November 16, 2011 | Volume: 4 | Issue: 6 | Pages: 640-646

10.1161/circoutcomes.111.961433 | PMID 22085984 Get It

Barriers to Telemedicine: Survey of Current Users in Acute Care Units
Rogove, Herbert J., Vespa, Paul , McArthur, David L. , Demaerschalk, Bart M.

Mayo Clinic

Telemedicine and e-Health | November 14, 2011 | Volume: 18 | Issue: 1 | Pages: 48-53

10.1089/tmj.2011.0071 | PMID 22082107 Get It

Improvement in Academic Behaviors After Successful Treatment of Convergence Insufficiency
Borsting, Eric , Mitchell, G. Lynn , Kulp, Marjean Taylor , Scheiman, Mitchell , Amster, Deborah, Coulter, Rachael A., Fecho, Gregory, Gallaway, Michael, Granet, David B. , Hertle, Richard W. , Rodena, Jacqueline, Yamada, Tomohiko , Group, the CITT Study, Cotter, Susan A. , Yamada, Tomohiko, Group, the CITT Study

Mayo Clinic

Optometry and Vision Science | November 11, 2011 | Volume: 89 | Issue: 1 | Pages: 12-18

10.1097/opx.0b013e318238ffc3 | PMID 22080400 Get It

ABSTRACT Purpose. To determine whether treatment of symptomatic convergence insufficiency (CI) has an effect on Academic Behavior Survey (ABS) scores. Methods. The ABS is a six‐item survey developed by the Convergence Insufficiency Treatment Trial Group that quantifies the frequency of adverse school behaviors and parental concern about school performance on an ordinal scale from 0 (never) to 4 (always) with total scores ranging from 0 to 24. The ABS was administered at baseline and after 12 weeks of treatment to the parents of 218 children aged 9 to 17 years with symptomatic CI, who were enrolled in the Convergence Insufficiency Treatment Trial and randomized into (1) home‐based pencil push‐ups; (2) home‐based computer vergence/accommodative therapy and pencil push‐ups; (3) office‐based vergence/accommodative therapy with home reinforcement; and (4) office‐based placebo therapy with home reinforcement. Participants were classified as successful (n = 42), improved (n = 60), or non‐responder (n = 116) at the completion of 12 weeks of treatment using a composite measure of the symptom score, nearpoint of convergence, and positive fusional vergence. Analysis of covariance methods were used to compare the mean change in ABS between response to treatment groups while controlling for the ABS score at baseline. Results. The mean ABS score for the entire group at baseline was 12.85 (SD = 6.3). The mean ABS score decreased (improved) in those categorized as successful, improved, and non‐responder by 4.0, 2.9, and 1.3 points, respectively. The improvement in the ABS score was significantly related to treatment outcome (p < 0.0001), with the ABS score being significantly lower (better) for children who were successful or improved after treatment as compared to children who were non‐responders (p = 0.002 and 0.043, respectively). Conclusions. A successful or improved outcome after CI treatment was associated with a reduction in the frequency of adverse academic behaviors and parental concern associated with reading and school work as reported by parents.
Immunoglobulin D amyloidosis: a distinct entity
Hayman, Suzanne R. , Dingli, David , Dispenzieri, Angela , Greipp, Philip R., Kumar, Shaji , Lacy, Martha Q. , Lust, John A., Leung, Nelson , Rajkumar, S. Vincent , Russell, Stephen J. , Zeldenrust, Steven R., Kyle, Robert A. , Gertz, Morie A. , Buadi, Francis K. , Mıkhael, Joseph , Roy, Vivek , Rajkumar, S Vincent , Leung, Nelson , Dispenzieri, Angela , Russell, Stephen J , Dingli, David

Mayo Clinic

Blood | November 8, 2011 | Volume: 119 | Issue: 1 | Pages: 44-48

10.1182/blood-2011-06-358895 | PMID 22065594 Get It

Abstract IgD monoclonal gammopathies are uncommon. They are seen rarely as a monoclonal gammopathy of undetermined significance and are present in 1%-2% of patients with multiple myeloma. In light-chain amyloidosis, IgD monoclonal proteins are found in ap-proximately 1% of patients. When an IgD monoclonal protein is found, amyloidosis is often omitted from the differential diagnosis. In the present study, we reviewed the natural history of IgD-associated amyloidosis among 53 patients seen over 41 years. The distribution of clinical syndromes suggests that these patients have a lower frequency of renal and cardiac involvement. The overall survival of these patients does not appear to be different from that of patients who have light-chain amyloidosis associated with another monoclonal protein.
Outcomes following surgery without radiotherapy for rectal cancer
Mathis, Kellie L. , Dozois, Eric J. , Huebner, Marianne , Haddock, Michael G. , Wolff, B. G., Nelson, Heidi , Pembérton, John H., Larson, David W. , Cima, Robert R.

Mayo Clinic

Journal of British Surgery | November 3, 2011 | Volume: 99 | Issue: 1 | Pages: 137-143

10.1002/bjs.7739 | PMID 22052336 Get It

Abstract Background This study determined survival and recurrence rates following curative resection of rectal cancer without radiotherapy. Methods This was a retrospective review of the Mayo Clinic database of patients with rectal cancer treated with curative intent using surgery alone from 1990 to 2006. Patients who received neoadjuvant chemotherapy or radiation therapy and those who had any postoperative radiotherapy were excluded. Details were collected from the database and patient records using a protocol approved by the institutional review board. Results Some 655 consecutive patients with rectal cancer treated with curative intent using surgery alone were identified; 397 had stage I disease, 125 stage II and 133 stage III. Four hundred and nine patients underwent anterior resection (AR) and 246 abdominoperineal resection (APR). Median follow-up was 62 months. The 5-year rate of local recurrence was 4·3 per cent, disease-free survival 90·0 per cent and cancer-specific survival 91·5 per cent. Stage-specific and all-stage disease-free survival did not differ significantly between AR and APR. The 5-year cumulative local recurrence rate was lower following AR than APR (3·6 versus 5·5 per cent; P = 0·321). There were only two patients with positive margins and type of operation was not significant on multivariable analysis. Conclusion Well-performed, standardized APRs have similar local recurrence to AR. Radiation therapy may not confer much additional benefit. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
Marks, Randolph S., Deschamps, Claude, Scanlon, Paul D., Olswold, Curtis L., Jiang, Ruoxiang , Swensen, Stephen J., Sun, Zhifu , Cunningham, Julie M. , Wampfler, Jason A. , Midthun, David E. , Andrade, Mariza de , Li, Yan , Limper, Andrew H. , Yang, Ping , Sun, Zhifu

Mayo Clinic

Cancer Prevention Research | November 1, 2011 | Volume: 5 | Issue: 3 | Pages: 365-373

10.1158/1940-6207.capr-11-0243 | PMID 22044695 Get It

Abstract Chronic obstructive pulmonary disease (COPD) is a strong risk factor for lung cancer. Published studies about variations of genes encoding glutathione metabolism, DNA repair, and inflammatory response pathways in susceptibility to COPD were inconclusive. We evaluated 470 single-nucleotide polymorphisms (SNP) from 56 genes of these three pathways in 620 cases and 893 controls to identify susceptibility markers for COPD risk, using existing resources. We assessed SNP- and gene-level effects adjusting for sex, age, and smoking status. Differential genetic effects on disease risk with and without lung cancer were also assessed; cumulative risk models were established. Twenty-one SNPs were found to be significantly associated with risk of COPD (P &lt; 0.01); gene-based analyses confirmed two genes (GCLC and GSS) and identified three additional genes (GSTO2, ERCC1, and RRM1). Carrying 12 high-risk alleles may increase risk by 2.7-fold; eight SNPs altered COPD risk without lung cancer by 3.1-fold and 4 SNPs altered the risk with lung cancer by 2.3-fold. Our findings indicate that multiple genetic variations in the three selected pathways contribute to COPD risk through GCLC, GSS, GSTO2, ERCC1, and RRM1 genes. Functional studies are needed to elucidate the mechanisms of these genes in the development of COPD, lung cancer, or both. Cancer Prev Res; 5(3); 365–73. ©2011 AACR.
Is It Dangerous to Quit Smoking Shortly before Surgery?
Shi, Yu , Warner, David O.

Mayo Clinic

Anesthesiology | October 26, 2011 | Volume: 115 | Issue: 5 | Pages: 1137-1138

10.1097/aln.0b013e3182326d6e | PMID 22027630 Get It

Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women
Limsui, David, Vierkant, Robert A. , Tillmans, Lori S. , Wang, Alice H., Weisenberger, Daniel J. , Lynch, Charles F. , Anderson, Kristin E. , French, Amy J. , Haile, Robert W. , Harnack, Lisa , Potter, John D. , Smyrk, Thomas C. , Thibodeau, Stephen N. , Cerhan, James R. , Laird, Peter W. , Slager, Susan L. , Limburg, Paul J. , Cerhan, James R , Vierkant, Robert A , Haile, Robert W , Potter, John D

Mayo Clinic

Gut | October 25, 2011 | Volume: 61 | Issue: 9 | Pages: 1299-1305

10.1136/gutjnl-2011-300719 | PMID 22027477 Get It

Background Postmenopausal hormone (PMH) therapy may reduce colorectal cancer (CRC) risk, but existing data are inconclusive. Objectives To evaluate associations between PMH therapy and incident CRC, overall and by molecularly defined subtypes, in the population-based Iowa Women's Health Study of older women. Methods Exposure data were collected from Iowa Women's Health Study participants (55–69 years) at baseline (1986). Archived, paraffin-embedded tissue specimens for 553 CRC cases were collected and analysed to determine microsatellite instability (MSI-L/MSS or MSI-H), CpG island methylator phenotype (CIMP-negative or CIMP-positive) and BRAF mutation ( BRAF -wildtype or BRAF -mutated) status. Multivariable Cox regression models were fit to estimate RRs and 95% CIs. Results PMH therapy (ever vs never use) was inversely associated with incident CRC overall (RR=0.82; 95% CI 0.72 to 0.93), with a significantly lower risk for MSI-L/MSS tumours (RR=0.75; 95% CI 0.60 to 0.94), and borderline significantly lower risks for CIMP-negative (RR=0.79; 95% CI 0.63 to 1.01) and BRAF -wildtype (RR=0.83; 95% CI 0.66 to 1.04) tumours. For PMH therapy >5 years, the subtype-specific risk estimates for MSI-L/MSS, CIMP-negative and BRAF -wildtype tumours were: RR=0.60, 95% CI 0.40 to 0.91; RR=0.68, 95% CI 0.45 to 1.03; and RR=0.70, 95% CI 0.47 to 1.05, respectively. PMH therapy was not significantly associated with the MSI-H, CIMP-positive or BRAF -mutated CRC subtypes. Conclusions In this prospective cohort study, PMH therapy was inversely associated with distinct molecularly defined CRC subtypes, which may be related to differential effects from oestrogen and/or progestin on heterogeneous pathways of colorectal carcinogenesis.
Overlooked and Underserved: “Action Signs” for Identifying Children With Unmet Mental Health Needs
Jensen, Peter S. , Goldman, Eliot, Offord, David, Huff, Barbara, Crowe, Maura, Amsel, Lawrence , Bennett, Kathryn , Bird, Héctor , Conger, Rand D., Fisher, Prudence W. , Kessler, Ronald C. , Roberts, Robert E., Costello, E. Jane , Friedman, Robert , Hoagwood, Kimberly

Mayo Clinic

Pediatrics | October 25, 2011 | Volume: 128 | Issue: 5 | Pages: 970-979

10.1542/peds.2009-0367 | PMID 22025589 Get It

OBJECTIVE: The US Surgeon General has called for new approaches to close the mental health services gap for the large proportion of US children with significant mental health needs who have not received evaluation or services within the previous 6 to 12 months. In response, investigators sought to develop brief, easily understood, scientifically derived “warning signs” to help parents, teachers, and the lay public to more easily recognize children with unmet mental health needs and bring these children to health care providers' attention for evaluation and possible services. METHOD: Analyses of epidemiologic data sets from &gt;6000 children and parents were conducted to (1) determine the frequency of common but severely impairing symptom profiles, (2) examine symptom profile frequencies according to age and gender, (3) evaluate positive predictive values of symptom profiles relative to Diagnostic and Statistical Manual of Mental Disorders diagnoses, and (4) examine whether children with 1 or more symptom profiles receive mental health services. RESULTS: Symptom-profile frequencies ranged from 0.5% to 2.0%, and 8% of the children had 1 or more symptom profile. Profiles generated moderate-to-high positive predictive values (52.7%–75.4%) for impairing psychiatric diagnoses, but fewer than 25% of children with 1 or more profiles had received services in the previous 6 months. CONCLUSIONS: Scientifically robust symptom profiles that reflect severe but largely untreated mental health problems were identified. Used as “action signs,” these profiles might help increase public awareness about children's mental health needs, facilitate communication and referral for specific children in need of evaluation, and narrow the child mental health services gap.
Propofol Induction Resulting in Green Urine Discoloration
Barbara, David W. , Whalen, Francis X. , Hemmings, Hugh C.

Mayo Clinic

Anesthesiology | October 22, 2011 | Volume: 116 | Issue: 4 | Pages: 924-924

10.1097/aln.0b013e31823a13bc | PMID 22024711 Get It